| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 01/28/1999 | WO1999003882A2 Human leukocyte calcium activated potassium channel polypeptide |
| 01/28/1999 | WO1999003881A2 Chimeric polypeptide comprising the fragment b of shiga toxin and peptides of therapeutic interest |
| 01/28/1999 | WO1999003870A1 2-fluorofucosyl-n-aroylglucosamine derivatives, intermediates therefor, and processes for producing these |
| 01/28/1999 | WO1999003828A1 Dihomo-seco-cholestanes with two unsaturated bones in the side chain |
| 01/28/1999 | WO1999003502A1 LO-CD2a ANTIBODY AND USES THEREOF FOR INHIBITING T CELL ACTIVATION AND PROLIFERATION |
| 01/28/1999 | WO1999003499A1 Cellular vesicle called ''exosome'', preparation and use thereof in immune stimulation |
| 01/28/1999 | WO1999003479A1 Lipid-based immune modulator composition |
| 01/28/1999 | WO1999003365A1 Nutritional composition containing methionine |
| 01/28/1999 | WO1998049303A3 Compositions and methods for conferring tick immunity and preventing tick borne diseases |
| 01/28/1999 | WO1998049138A3 Vitamin d3 analogs with bis c-20 side chains |
| 01/28/1999 | WO1998044913A3 Compositions containing mkc-442 in combination with other antiviral agents |
| 01/28/1999 | WO1998037200A3 Antibody fragment-polymer conjugates and humanized anti-il-8 monoclonal antibodies |
| 01/28/1999 | CA2297436A1 2-fluorofucosyl-n-aroylglucosamine derivatives, intermediates therefor, and processes for producing these |
| 01/28/1999 | CA2296666A1 T-cell receptor beta-like protein |
| 01/28/1999 | CA2296145A1 Dihomo-seco-cholestanes with two unsaturated bonds in the side chain |
| 01/28/1999 | CA2295690A1 Lipid-based immune modulator composition |
| 01/28/1999 | CA2237155A1 A yak-1 related serine/threonine protein kinase-htlar33 |
| 01/27/1999 | EP0893507A1 Use of MHC class II ligands (CD4 and LAG-3) as adjuvant for vaccination and of LAG-3 in cancer treatment |
| 01/27/1999 | EP0893501A2 Ferrichrome transport atp-binding protein |
| 01/27/1999 | EP0893498A2 cDNA clone MY1 that encodes a novel human 7-transmembrane receptor |
| 01/27/1999 | EP0893493A2 Genetically modified cells and their use for prophylaxis or treatment of diseases |
| 01/27/1999 | EP0893449A1 Antitumor substance extracted from hen-of-the-woods |
| 01/27/1999 | EP0892849A1 Methods for using the obese gene and its gene product to stimulate hematopoietic development |
| 01/27/1999 | EP0892795A1 Piperidinylpyramidine derivatives |
| 01/27/1999 | EP0892794A1 Acylated n-hydroxy methyl thalidomide prodrugs with immunomodulator action |
| 01/27/1999 | EP0892791A1 Substituted benzenesulfonamide derivatives as prodrugs of cox-2 inhibitors |
| 01/27/1999 | EP0892643A1 Methods for inhibiting an immune response by blocking the gp39/cd40 and ctla4/cd28/b7 pathways and compositions for use therewith |
| 01/27/1999 | EP0892642A1 Use in a composition of an extract of at least one labiate |
| 01/27/1999 | EP0892640A2 Enteric-coated pharmaceutical compositions of mycophenolate |
| 01/27/1999 | CN1206414A N-acyl-2-substituted-4-(benzimidazolyl-or imidazopyridinyl-substituted pesidues)-piperidines as tachykinin antagonists |
| 01/27/1999 | CN1206405A Imides as PDE III, PDE IV and TNF inhibitors |
| 01/27/1999 | CN1206350A Hybrid with interferon-'alpha' and immunoglobulin Fc linkes through non-immunogenic peptide |
| 01/27/1999 | CN1206348A Extracts of shark cartilage |
| 01/26/1999 | US5864028 Degradation resistant mRNA derivatives linked to TNF-α ribozymes |
| 01/26/1999 | US5863949 Reacting carboxylic acid derivative with 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide, 1-hydroxybenzenetriazole and hydroxylamine; treats diseases involving production of tumor necrosis factor in a mammal |
| 01/26/1999 | US5863931 Amidino derivatives and their use as nitric oxide synthase inhibitors |
| 01/26/1999 | US5863926 4,4-(disubstituted)cyclohexan-1-carboxylate monomers and related compounds |
| 01/26/1999 | US5863889 ICAM-1/LFA-1 short-chain peptides and method of using same |
| 01/26/1999 | US5863796 Immunizing a mammal with specific polypeptide and collecting the antibody |
| 01/26/1999 | US5863779 UBC7-like ubiquitin-conjugating enzyme |
| 01/26/1999 | US5863777 DNA encoding alanyl tRNA synthetase from streptococcus pneumonine |
| 01/26/1999 | US5863766 Isolated, pure polynucleotide encoding a polypeptide for treating vesicle trafficking, immunological, and neoplastic disorders. |
| 01/26/1999 | US5863541 Proteins in cells |
| 01/26/1999 | US5863528 Porcine cytokines |
| 01/26/1999 | CA2166692C Novel 9-n-bicyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines |
| 01/26/1999 | CA2137639C Vaccine composition comprising autologous epidermal growth factor or a fragment or a derivate thereof having anti-tumor activity and use thereof in the therapy of malignant diseases |
| 01/26/1999 | CA2131373C 2-aminosugar derivatives of macrolides |
| 01/26/1999 | CA1340329C Superoxide dismutasee |
| 01/25/1999 | CA2238655A1 Cdna clone my1 that encodes a novel human 7-transmembrane receptor |
| 01/23/1999 | CA2238667A1 Novel ferrichrome transport atp-binding protein |
| 01/21/1999 | WO1999002713A1 Pseudomonas exotoxin a-like chimeric immunogens |
| 01/21/1999 | WO1999002696A1 Endogenetic retroviral sequences, associated with autoimmune diseases or with pregnancy disorders |
| 01/21/1999 | WO1999002675A1 G-coupled receptor showing selective affinity for atp |
| 01/21/1999 | WO1999002563A1 Ligand for herpes simplex virus entry mediator and methods of use |
| 01/21/1999 | WO1999002561A1 Human f11 antigen: a cell surface receptor involved in platelet aggregation |
| 01/21/1999 | WO1999002547A1 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases |
| 01/21/1999 | WO1999002546A1 123 human secreted proteins |
| 01/21/1999 | WO1999002528A1 Novel compounds |
| 01/21/1999 | WO1999002505A1 Il-5 inhibiting 6-azauracil derivatives |
| 01/21/1999 | WO1999002504A1 6-azauracil derivatives as il-5 inhibitors |
| 01/21/1999 | WO1999002186A2 Antigen delivery system comprising monoglyceride or diglyceride derivatives as adjuvant |
| 01/21/1999 | WO1998043657A3 Graminae pollen allergen mutants for specific immunotherapy, and production and use of the same |
| 01/21/1999 | CA2298834A1 Endogenetic retroviral sequences, associated with autoimmune diseases or with pregnancy disorders |
| 01/21/1999 | CA2295626A1 Novel compounds |
| 01/21/1999 | CA2295474A1 123 human secreted proteins |
| 01/21/1999 | CA2295237A1 Antigen delivery system comprising monoglyceride or diglyceride derivatives as adjuvant |
| 01/21/1999 | CA2294533A1 6-azauracil derivatives as il-5 inhibitors |
| 01/21/1999 | CA2294145A1 Il-5 inhibiting 6-azauracil derivatives |
| 01/21/1999 | CA2237698A1 Genetically modified cells and their use in the prophylaxis or therapy of disorders |
| 01/20/1999 | EP0892063A2 Histidine kinase |
| 01/20/1999 | EP0892061A2 The Chlamydia trachomatis Glutamyl-tRNAGln amidotransferase subunit ratB |
| 01/20/1999 | EP0892060A2 The Chlamydia trachomatis Glutamyl-tRNAGln amidotransferase subunit ratA |
| 01/20/1999 | EP0892051A2 CDNA Clone heoad54 that encodes a human 7 transmembrane receptor |
| 01/20/1999 | EP0891985A1 Process for the production of biologically active protein (e.g. TGF) |
| 01/20/1999 | EP0891984A2 Nucleic acid encoding streptococcus pneumoniae response regulator |
| 01/20/1999 | EP0891983A1 Novel tarF |
| 01/20/1999 | EP0891982A2 HIV peptides |
| 01/20/1999 | EP0891770A1 Killer T cell activator and use thereof |
| 01/20/1999 | EP0891719A1 Nutritional composition containing methionine |
| 01/20/1999 | EP0891429A2 Recombinant aav vector-based transduction system and use of same |
| 01/20/1999 | EP0891425A2 Methods and compositions for regulating t cell subsets by modulating transcription factor activity |
| 01/20/1999 | EP0891377A1 Inhibitor and stimulator of stem cell proliferation and uses thereof |
| 01/20/1999 | EP0891375A1 Peptidyl compounds having mmp and tnf- liberation inhibitory activity |
| 01/20/1999 | EP0891347A1 Triterpene derivatives with immunosuppressant activity |
| 01/20/1999 | EP0891332A1 6-phenylpyridyl-2-amine derivatives |
| 01/20/1999 | EP0891326A1 Novel vitamin d analogues |
| 01/20/1999 | EP0891189A1 Medicament for optimising mucosal viscosity and stimulating intestinal function |
| 01/20/1999 | EP0792288B1 Conjugates of bdnf and nt-3 with a water-soluble polymer |
| 01/20/1999 | EP0689428B1 Enhanced circulation effector composition and method |
| 01/20/1999 | EP0674624B1 Pyrazoles having crf antagonist activity |
| 01/20/1999 | EP0641327B1 Novel alpha-mannosidase inhibitors |
| 01/20/1999 | EP0630245B1 Protein kinase c inhibitor |
| 01/20/1999 | EP0445228B1 Immunotherapy involving cd28 stimulation |
| 01/20/1999 | CN1205699A 1-(1,2-disubstituted piperidinyl)-4-substituted piperazine derivatives |
| 01/20/1999 | CN1205328A Sulfonylaminocarboxylic acids |
| 01/20/1999 | CN1205205A Pyrazolopyridine compound and processes for preparation thereof |
| 01/20/1999 | CN1041726C Method for preparing 1,3-dihydro-2h-imidzo [4,5,6] quinoline-2-one derivatives |
| 01/19/1999 | US5861512 Reaction of 2-tert-butylcarboxamidepiperazine with acid in solvent, heating, dissolving, cooling, precipitation of crystals |
| 01/19/1999 | US5861510 Antiarthritic agents, antiulcer agents, restenosis, oral diseases |
| 01/19/1999 | US5861493 Process for the synthesis of 2'-O-substituted pyrimidines |